• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY Back to Search Results
Model Number 610-0001
Device Problems Improper or Incorrect Procedure or Method (2017); Device Dislodged or Dislocated (2923)
Patient Problems Corneal Clouding/Hazing (1878); Inflammation (1932); Keratitis (1944); Blurred Vision (2137); Visual Impairment (2138); Loss of Vision (2139)
Event Date 12/01/2016
Event Type  Injury  
Manufacturer Narrative
The explanted device is expected to be returned to the manufacturer.The device history record (dhr) for this manufacturing lot was reviewed and the device met all release criteria and there were no discrepancies or unusual findings that relate to the reported event.Inlay decentration is listed in the device labeling as a known complication of corneal inlay surgery.Dlk is also listed in the device labeling and is commonly associated with corneal flap procedures.The off-label use of celluvisc may have been contributory.Complaint reference number: (b)(4).Date emdr submitted to fda: 12/21/2016.
 
Event Description
Corneal inlay implantation was performed on (b)(6) 2016 on the left eye.At the one-day postoperative visit, the patient presented with blurred vision and inflammation in the operative eye and diffuse lamellar keratitis (dlk), grade 2, was diagnosed.Steroid administration was increased to hourly.The patient's preoperative best corrected distance visual acuity (bcdva) was 20/20.During investigation of the reported issue, it was discovered that at the end of the procedure several drops of celluvisc had been instilled on the corneal flap.New information was received on november 23, 2015 indicating that the inlay will be explanted.Additional information was requested and on december 15, 2016 the surgeon provided the following update.Initially, the patient's postoperative bcdva decreased from 20/20 to 20/100, but improved to 20/40 on (b)(6) 2016.Prior to inlay explantation the inlay was clear and dlk had decreased to grade 1, but the inlay had decentered nasally.On (b)(6) 2016, the flap was lifted and irrigated and the inlay was removed and replaced with a new inlay in order to address decentering (and dlk).
 
Manufacturer Narrative
The explanted inlay was returned to the manufacturer and subjected to visual microscopic inspection.The findings revealed that the inlay was folded and dehydrated.As a result no dimensional measurements could be performed.Complaint reference# (b)(4).Date esmdr submitted: 03/02/2017.
 
Event Description
Two weeks post inlay exchange, the patient's best corrected distance visual acuity (bcdva) remained unchanged at 20/40.On (b)(6) 2017, bcdva improved to 20/30.There is residual mild corneal haze observed just outside the area of inlay.Steroid treatment is being tapered.
 
Manufacturer Narrative
Correction for 3005956347-2016-00011-001: [correct information for received by mfr date is 02/01/2017 and not 01/27/2017].(b)(4).
 
Event Description
Patient's current status was requested and the following update was provided on august 1, 2017: the patient was last examined on (b)(6) 2017, the patient's best corrected visual acuity (bcdva) was 20/40 and the patient was directed to continue artificial tears.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAINDROP NEAR VISION INLAY
Type of Device
CORNEAL INLAY
Manufacturer (Section D)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer (Section G)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer Contact
pushpita singh
25651 atlantic ocean dr.,
ste. a1
lake forest, CA 92630-8835
9497072740
MDR Report Key6194508
MDR Text Key62982029
Report Number3005956347-2016-00011
Device Sequence Number1
Product Code LQE
UDI-Device Identifier10850394006013
UDI-Public(01)10850394006013(17)190808(10)002979
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 08/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/08/2019
Device Model Number610-0001
Device Catalogue NumberRD1-1
Device Lot Number002979
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer12/27/2016
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/23/2016
Initial Date FDA Received12/21/2016
Supplement Dates Manufacturer ReceivedNot provided
08/01/2017
Supplement Dates FDA Received03/02/2017
08/05/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/08/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number3005956347-02/03/17-001
Patient Sequence Number1
Treatment
CELLUVISC ARTIFICIAL TEARS; FEMTOSECOND LASER FOR CREATION OF CORNEAL FLAP
Patient Outcome(s) Required Intervention;
Patient Age49 YR
-
-